New York, NY (PRWEB) November 12, 2013
The diabetes drug safety center at DrugRisk.com is alerting patients taking the medications Januvia or Janumet of new information on the site. A federal court overseeing a growing number of lawsuits alleging drugs like these caused pancreatic cancer has set the next hearing for next week. The formal case is known as In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452 (Southern District of California).
The DrugRisk Center was created to give those taking popular prescription drugs the latest product recalls, safety alerts, research and litigation news. Patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.
Januvia and Janumet are popular oral diabetes medications prescribed to those with type-2 diabetes, taken twice a day to lower blood sugar levels. In recent years, they have been the best-selling drugs for pharmaceutical company Merck*.
However, DrugRisk has added studies warning of a risk of Januvia cancer. In 2011, researchers from UCLA discovered subjects given Januvia had increased rates of pancreatic cancer and thyroid cancer**. The American Medical Association recently advised diabetes drugs like these can double the risk of pancreatitis, a major risk factor for pancreatic cancer***.
Due to the number of patients who have filed a Januvia lawsuit alleging cancer, cases have been consolidated to a special federal multidistrict litigation court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California).
DrugRisk has added the latest court records showing 150 cases have already been filed alleging cancer from the drug class including Januvia, Byetta, Janumet or Victoza****. Judge Anthony Battaglia, who is overseeing the litigation, has scheduled the next Status Conference for November 21, 2013.
Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.
For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****Judicial Panel on Multidistrict Litigation, 10/17/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf
Read the full story at http://www.prweb.com/releases/januvia-warnings-2013/side-effects-lawsuit/prweb11327985.htm.
Copyright©2012 Vocus, Inc.
All rights reserved